Skip to main content

Peer Review reports

From: Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort study

Original Submission
23 Jan 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Mar 2023 Reviewed Reviewer Report - Chi-Lu Chiang
18 Apr 2023 Reviewed Reviewer Report
1 May 2023 Author responded Author comments - Yongchang Zhang
Resubmission - Version 3
1 May 2023 Submitted Manuscript version 3
Publishing
11 May 2023 Editorially accepted
16 May 2023 Article published 10.1186/s12885-023-10952-w

You can find further information about peer review here.

Back to article page